OptiMed, based in Ettlingen/Germany, was founded in 1995. The company is engaged in the research and development, production and global distribution of medical products for minimal invasive therapy. OptiMed employs more than 100 people in its administration center and 2 production sites in Ettlingen near Karlsruhe.
As OptiMed continuously invests in the research, development and production of the products of tomorrow, we are the ideal partner for innovative medical practitioners working in the field of minimal invasive therapy, specifically in
At OptiMed Medizinische Instrumente GmbH, our objective is to serve the wellbeing of the patient and enhance the expertise of the medical practitioner, supply optimum training for distributors and secure long-term employment for its qualified staff.
Developing and producing medical instruments represents not only an enormous challenge but also a high degree of responsibility. Our objective is to serve the wellbeing of the patient, by relieving suffering, prolonging and saving life with the products we develop and produce today. Our awareness of this responsibility powers every level of our company.
Manufacturing the products of tomorrow requires continuous research and intensive cooperation on a global basis with medical practitioners working in minimal invasive therapy. At OptiMed, our willingness to pursue and implement even the most complex ideas have made us a leading innovator in many areas of minimal invasive techniques. OptiMed also supports and organizes training in the form of workshops and practical internships.
OptiMed's primary objective is to act as a reliable partner for medical practitioners. A partner who responds to every need and implements these ideas in optimal products.
OptiMed products are available in over 40 countries around the world. Our production sites are located in Germany and guarantees consistent and continuous quality for these products. OptiMed products are distributed in Germany by qualified medical product consultants, and internationally by a network of dealers with exclusive distribution of OptiMed products. OptiMed attaches importance to ongoing training of all sales and distribution representatives, ensuring customers receive optimum support.
Continuous optimization of medical products and processes demands employees with qualifications that exceed the norm. Our staff stands out for their high degree of motivation, flexibility of approach and permanent willingness to extend their knowledge to explore new directions. OptiMed prepares its staff for the ever-increasing demands of the medical field by organizing training courses and events - securing jobs, creating new employment over the medium term and generating the long-term loyalty of our valuable staff.
Quality is a consideration that affects every sector of our company. It involves the provision of products and services that fulfil our customers' requirements – so that delighting our customers is a central criterion in our definition of quality.
We improve the quality of our products and services by working to precise specifications, a method which enables positive improvements to be compared and measured on a continuous basis and which generates three key results .
These strategic targets are critical to optimizing the quality and competitive edge of our products and services in global markets.
Development and advancement of innovative products for medical applications, primarily for minimally invasive therapy:
OptiMed conducts research, development and production of products in the field of minimal invasive medical technology to the highest quality standards. Our production of these "products of tomorrow" is founded on ongoing research and permanent processes of learning and advancement. At OptiMed, our willingness to pursue and implement even the most complex ideas have made us a leading innovator in many areas of minimal invasive techniques, including the sinus-Stent family, the products Cemento-RE and CementoPlus, the dilatation catheter range (Dilexx-18, P1, Zelos, Mars, Star), the CO2 Angio-set and the ureteral stent range (Opti-J, OptiPur, OptiSoft).
Our company markets a portfolio of over 5000 products nationally and internationally in over 40 countries. Obtaining country-specific approvals for medical products is a process involving the knowledge, awareness, fulfilment and implementation of a wide array of standards, guidelines and official directives and laws.
Our staff has long-standing experience in the field of medical product approval, enabling us to meet both national and European requirements (CE certification) and international specifications.We have the speed and expertise to launch new products rapidly – benefiting our company and our customers.
As manufacturers of many of the products mentioned, we have acquired and developed extensive processing knowledge and skills for a variety of materials.
One of the main points is the processing of nitinol, a metal alloy made from nickel and titanium with the special feature of "shape memory". Nitinol is the material of choice for our entire stent program. The self-expanding nitinol stent responds to body temperature, adopting its "pre-programmed" shape. A "sine structure" gives the stent exceptional flexibility and radial force. Areas of application include blood vessels, the biliary duct or oesophagus.
In addition to processing nitinol, we are specialists in processing a variety of tubing materials, particularly PTFE, polyurethane and polyethylene, primarily used for products including delivery system for our stent systems, ureteral stents and drainages.
Our primary objective is the continuous implementation of our corporate philosophy: serving patients' wellbeing worldwide by supplying outstanding product quality and keeping pace with current medical requirements. We transfer the high quality of our sales and service to our customers, guaranteeing the wellbeing of their patients.